2016 European Guidelines on cardiovascular disease prevention in clinical practice.

Authors/Task Force Members: Massimo F. Piepoli* (Chairperson) (Italy), Arno W. Hoes* (Co-Chairperson) (The Netherlands), Stefan Agewall (Norway)1, Christian Albus (Germany)9, Carlos Brotons (Spain)10, Alberico L. Catapano (Italy)3, Marie-Therese Cooney (Ireland)1, Ugo Corrà (Italy)1, Bernard Cosyns (Belgium)1, Christi Deaton (UK)1, Ian Graham (Ireland)1, Michael Stephen Hall (UK)7, F. D. Richard Hobbs (UK)10, Maja-Lisa Løchen (Norway)1, Herbert Löllgen (Germany)8, Pedro Marques-Vidal (Switzerland)1, Joep Perk (Sweden)1, Eva Prescott (Denmark)1, Josep Redon (Spain)5, Dimitrios J. Richter (Greece)1, Naveed Sattar (UK)2, Yvo Smulders (The Netherlands)1, Monica Tiberi (Italy)1, H. Bart van der Worp (The Netherlands)6, Ineke van Dis (The Netherlands)4, W. M. Monique Verschuren (The Netherlands)1

[1]  F. Beyer,et al.  Effectiveness of brief alcohol interventions in primary care populations. , 2018, The Cochrane database of systematic reviews.

[2]  J. Ottervanger,et al.  Prognostic Value of Coronary Artery Calcium Scoring in Addition to Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging in Symptomatic Patients , 2016, Circulation. Cardiovascular imaging.

[3]  Stefan Störk,et al.  EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries , 2016, European journal of preventive cardiology.

[4]  M. Fischereder,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.

[5]  S. Glantz,et al.  E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. , 2016, The Lancet. Respiratory medicine.

[6]  P. Dehghani,et al.  Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome , 2016, Circulation.

[7]  M. Smits,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[8]  S. Solomon,et al.  Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. , 2015, The New England journal of medicine.

[9]  F. Hu,et al.  Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. , 2015, The lancet. Diabetes & endocrinology.

[10]  H. Burr,et al.  Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals , 2015, The Lancet.

[11]  Harlan M. Krumholz,et al.  Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). , 2015, Journal of the American College of Cardiology.

[12]  H. McGee,et al.  Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology , 2015, European journal of preventive cardiology.

[13]  J. Petersen,et al.  Coronary heart disease incidence among non-Western immigrants compared to Danish-born people: effect of country of birth, migrant status, and income , 2015, European journal of preventive cardiology.

[14]  N. Sattar,et al.  Postnatal testing following gestational diabetes: time to replace the oral glucose tolerance test? , 2015, The lancet. Diabetes & endocrinology.

[15]  Jennifer G. Robinson,et al.  Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. , 2015, The New England journal of medicine.

[16]  Hyuk-Jae Chang,et al.  Incremental benefit of coronary artery calcium score above traditional risk factors for all-cause mortality in asymptomatic Korean adults. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[17]  Ersen B. Colkesen,et al.  Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk , 2015, Heart.

[18]  M. Pencina,et al.  Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. , 2015, The New England journal of medicine.

[19]  D. Matthews,et al.  Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140–149 , 2015, Diabetes Care.

[20]  Daniel F. Freitag,et al.  Association of Cardiometabolic Multimorbidity With Mortality. , 2015, JAMA.

[21]  Hao Li,et al.  Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes , 2015, Circulation.

[22]  K. Bennett,et al.  A Survey of GPs Awareness and Use of Risk Assessment Tools and Cardiovascular Disease Prevention Guidelines. , 2015, Irish medical journal.

[23]  M. Woodward,et al.  Kidney measures beyond traditional risk factors for cardiovascular prediction: A collaborative meta-analysis , 2015, The lancet. Diabetes & endocrinology.

[24]  V. Fuster,et al.  Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study , 2015, Circulation.

[25]  E. Falk,et al.  The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30 824 Europeans: the Copenhagen General Population Study , 2015, European heart journal.

[26]  Ross A. Hammond,et al.  Smart food policies for obesity prevention , 2015, The Lancet.

[27]  Finn Gyntelberg,et al.  Ranking of psychosocial and traditional risk factors by importance for coronary heart disease: the Copenhagen City Heart Study. , 2015, European heart journal.

[28]  Olle Melander,et al.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.

[29]  Walter Desmet,et al.  ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. , 2015, European heart journal.

[30]  Marc P. Bonaca,et al.  Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.

[31]  Gretchen A. Stevens,et al.  A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. , 2015, The lancet. Diabetes & endocrinology.

[32]  C. Ballantyne,et al.  Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. , 2015, The American journal of cardiology.

[33]  A. Abernethy,et al.  Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. , 2015, JAMA internal medicine.

[34]  L. Goldman,et al.  Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States , 2015, Annals of Internal Medicine.

[35]  Jennifer G. Robinson,et al.  Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. , 2015, The New England journal of medicine.

[36]  K. Shimada,et al.  Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years of Older With Atherosclerotic Risk-Factors: A Randomized Clinical Trial , 2015 .

[37]  Andrew E Moran,et al.  Demographic and epidemiologic drivers of global cardiovascular mortality. , 2015, The New England journal of medicine.

[38]  D. Calhoun,et al.  Obstructive sleep apnea, hypertension and cardiovascular diseases , 2015, Journal of Human Hypertension.

[39]  Tom R. Gaunt,et al.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.

[40]  Lawrence A Leiter,et al.  Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management , 2015, European heart journal.

[41]  K. Rahimi,et al.  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.

[42]  D. Asch,et al.  Wearable devices as facilitators, not drivers, of health behavior change. , 2015, JAMA.

[43]  T. Jørgensen,et al.  Psychological consequences of screening for cardiovascular risk factors in an un-selected general population: Results from the Inter99 randomised intervention study , 2015, Scandinavian journal of public health.

[44]  Hynek Pikhart,et al.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.

[45]  David E Newby,et al.  Expert position paper on air pollution and cardiovascular disease. , 2015, European heart journal.

[46]  M. Kivimaki,et al.  The natural course of healthy obesity over 20 years. , 2015, Journal of the American College of Cardiology.

[47]  B. Zinman,et al.  Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. , 2015, JAMA.

[48]  S. Wild,et al.  Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. , 2015, JAMA.

[49]  Rosy Tirimacco,et al.  Alternative models of cardiac rehabilitation: A systematic review , 2015, European journal of preventive cardiology.

[50]  D. Margolis,et al.  Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study , 2014, Annals of the rheumatic diseases.

[51]  U. Ekelund,et al.  Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC) , 2015, BDJ.

[52]  R. Califf,et al.  Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. , 2015, The New England journal of medicine.

[53]  J. Shaw,et al.  Glycemic control and excess mortality in type 1 diabetes. , 2015, The New England journal of medicine.

[54]  V. Perkovic,et al.  HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis , 2014, Cochrane Database of Systematic Reviews.

[55]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[56]  C. Bullen,et al.  Electronic cigarettes for smoking cessation and reduction. , 2014, The Cochrane database of systematic reviews.

[57]  R. Taylor,et al.  Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. , 2014, International journal of cardiology.

[58]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.

[59]  Braunwald,et al.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. , 2014, The New England journal of medicine.

[60]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.

[61]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.

[62]  M. Døssing,et al.  A systematic review of health effects of electronic cigarettes. , 2014, Preventive medicine.

[63]  J. Redón,et al.  Prognostic Value of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension , 2014, Hypertension.

[64]  V. Fuster,et al.  A polypill strategy to improve adherence: results from the FOCUS project. , 2014, Journal of the American College of Cardiology.

[65]  R. Sacco,et al.  Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. , 2014, JACC. Cardiovascular imaging.

[66]  M. Budoff,et al.  The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review. , 2014, Atherosclerosis.

[67]  Charles H. Hillman,et al.  Effects of the FITKids Randomized Controlled Trial on Executive Control and Brain Function , 2014, Pediatrics.

[68]  M. Cerqueira,et al.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2014, European heart journal cardiovascular Imaging.

[69]  N. Williams.  The Oxford Handbook of Health Communication, Behavior Change, and Treatment Adherence , 2014 .

[70]  M. Woodward,et al.  Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.

[71]  S. Blair,et al.  Leisure-time running reduces all-cause and cardiovascular mortality risk. , 2014, Journal of the American College of Cardiology.

[72]  Elizabeth Dunford,et al.  Target Salt 2025: A Global Overview of National Programs to Encourage the Food Industry to Reduce Salt in Foods , 2014, Nutrients.

[73]  F. Hu,et al.  Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies , 2014, BMJ : British Medical Journal.

[74]  K. Michaëlsson,et al.  Discontinuation of Smokeless Tobacco and Mortality Risk After Myocardial Infarction , 2014, Circulation.

[75]  A. Wierzbicki,et al.  Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance , 2014, BMJ : British Medical Journal.

[76]  Hynek Pikhart,et al.  Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data , 2014, BMJ : British Medical Journal.

[77]  J. König,et al.  Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis , 2014, Diabetologia.

[78]  A. Ferro,et al.  The PlA1/A2 Polymorphism of Glycoprotein IIIa as a Risk Factor for Myocardial Infarction: A Meta-Analysis , 2014, PloS one.

[79]  J. Critchley,et al.  An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[80]  G. Mancia,et al.  Improving long-term prediction of first cardiovascular event: the contribution of family history of coronary heart disease and social status. , 2014, Preventive medicine.

[81]  F. Hu,et al.  Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis. , 2014, The American journal of clinical nutrition.

[82]  N. Sattar,et al.  Lessons from SAVOR and EXAMINE: some important answers, but many open questions. , 2014, Journal of diabetes and its complications.

[83]  Marlien Varnfield,et al.  Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial , 2014, Heart.

[84]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[85]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[86]  W. Rathmann,et al.  Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States , 2014, BMJ : British Medical Journal.

[87]  T. Jørgensen,et al.  Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial , 2014, BMJ : British Medical Journal.

[88]  G. Roglić,et al.  Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. , 2014, The lancet. Diabetes & endocrinology.

[89]  S. Beach,et al.  Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. , 2014, JAMA internal medicine.

[90]  L. Diller,et al.  Routine Echocardiography Screening for Asymptomatic Left Ventricular Dysfunction in Childhood Cancer Survivors: A Model-Based Estimation of the Clinical and Economic Effects , 2014, Annals of Internal Medicine.

[91]  M. Borggrefe,et al.  Position paper on the importance of psychosocial factors in cardiology: Update 2013 , 2014, German medical science : GMS e-journal.

[92]  A. Witzki,et al.  Results of a workplace health campaign: what can be achieved? , 2014, Deutsches Arzteblatt international.

[93]  J. Geleijnse,et al.  LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies , 2014, British Journal of Nutrition.

[94]  S. Anderson,et al.  Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. , 2014, International journal of cardiology.

[95]  M. Mittleman,et al.  Outbursts of anger as a trigger of acute cardiovascular events: a systematic review and meta-analysis , 2014, BDJ.

[96]  G. MacGregor,et al.  Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality , 2014, BMJ Open.

[97]  O. Franco,et al.  Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies , 2014, BMJ : British Medical Journal.

[98]  Jbs Board.  Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) , 2014, Heart.

[99]  Viola Vaccarino,et al.  Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association , 2014, Circulation.

[100]  P. D. de Leeuw,et al.  Treatment of Hypertension in the Oldest Old: A Critical Role for Frailty? , 2014, Hypertension.

[101]  J. Boer,et al.  Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands , 2014, European journal of preventive cardiology.

[102]  W. Katon,et al.  Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the academy of psychosomatic medicine research and evidence-based practice committee. , 2014, Psychosomatics.

[103]  J. Etter,et al.  A longitudinal study of electronic cigarette users. , 2014, Addictive behaviors.

[104]  A. Husseini,et al.  A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries , 2014, PloS one.

[105]  A. Perkins,et al.  Effect of Collaborative Care for Depression on Risk of Cardiovascular Events: Data From the IMPACT Randomized Controlled Trial , 2014, Psychosomatic medicine.

[106]  W. Kraus,et al.  Psychosocial Benefits of Cardiac Rehabilitation Among Women Compared With Men , 2014, Journal of cardiopulmonary rehabilitation and prevention.

[107]  I. Ford,et al.  Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study , 2013, European heart journal.

[108]  P. Austin,et al.  Socioeconomic Status, Functional Recovery, and Long-Term Mortality among Patients Surviving Acute Myocardial Infarction , 2013, PloS one.

[109]  Christopher J. L. Murray,et al.  Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010: The Global Burden of Disease 2010 Study , 2013, Circulation.

[110]  C. Herrmann-Lingen,et al.  Psychokardiologie : praxisrelevante Erkenntnisse und Handlungsempfehlungen Psychocardiology : clinically relevant recommendations regarding selected cardiovascular diseases , 2014 .

[111]  R. Sacco,et al.  Coronary Artery Calcium and Incident Cerebrovascular Events in an Asymptomatic Cohort , 2014 .

[112]  S. Glantz,et al.  E-Cigarettes A Scientific Review , 2014 .

[113]  Michael W. Beets,et al.  Fitness vs. fatness on all-cause mortality: a meta-analysis. , 2014, Progress in cardiovascular diseases.

[114]  N. Pogosova,et al.  [Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery]. , 2014, Kardiologiia.

[115]  Shah Ebrahim,et al.  Promoting patient uptake and adherence in cardiac rehabilitation. , 2014, The Cochrane database of systematic reviews.

[116]  Walerian Piotrowski,et al.  Feasibility of home-based cardiac telerehabilitation: Results of TeleInterMed study. , 2014, Cardiology journal.

[117]  Wanghong Xu,et al.  Dietary fiber intake and risk of type 2 diabetes: a dose–response analysis of prospective studies , 2014, European Journal of Epidemiology.

[118]  D. Greenwood,et al.  Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis , 2013, BMJ.

[119]  Deepak L. Bhatt,et al.  Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. , 2013, JAMA.

[120]  B. Zinman,et al.  Are Metabolically Healthy Overweight and Obesity Benign Conditions? , 2013, Annals of Internal Medicine.

[121]  R. Sacco,et al.  Changes in Clinical and Microbiological Periodontal Profiles Relate to Progression of Carotid Intima‐Media Thickness: The Oral Infections and Vascular Disease Epidemiology Study , 2013, Journal of the American Heart Association.

[122]  Hayden McRobbie,et al.  Electronic cigarettes for smoking cessation: a randomised controlled trial , 2013, The Lancet.

[123]  R. Zhan,et al.  Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies. , 2013, Journal of psychiatric research.

[124]  M. Burg,et al.  Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. , 2013, American heart journal.

[125]  L. John,et al.  Financial incentives for exercise adherence in adults: systematic review and meta-analysis. , 2013, American journal of preventive medicine.

[126]  I. Perry,et al.  The effectiveness of workplace dietary modification interventions: a systematic review. , 2013, Preventive medicine.

[127]  K. Bennett,et al.  Explaining the Decline in Coronary Heart Disease Mortality in Portugal Between 1995 and 2008 , 2013, Circulation. Cardiovascular quality and outcomes.

[128]  Nish Chaturvedi,et al.  Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE—Southall And Brent REvisited) , 2013, Heart.

[129]  Deepak L. Bhatt,et al.  Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. , 2013, JAMA.

[130]  K. Stronks,et al.  Incidence of acute myocardial infarction in first and second generation minority groups: does the second generation converge towards the majority population? , 2013, International journal of cardiology.

[131]  Hassan Khan,et al.  Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. , 2013, European heart journal.

[132]  Craig Wilson,et al.  Alogliptin after acute coronary syndrome in patients with type 2 diabetes. , 2013, The New England journal of medicine.

[133]  Deepak L. Bhatt,et al.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.

[134]  K. Kotseva,et al.  Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey , 2013, European journal of preventive cardiology.

[135]  A. Dominiczak,et al.  2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. , 2013, Journal of hypertension.

[136]  P. Vardas,et al.  Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET study. , 2013, International journal of cardiology.

[137]  Josef Coresh,et al.  Cystatin C versus creatinine in determining risk based on kidney function. , 2013, The New England journal of medicine.

[138]  M. Bansal.  Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of , 2013 .

[139]  T. Marwick,et al.  Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis. , 2013, European journal of cancer.

[140]  E. Ingelsson,et al.  Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[141]  V. Salomaa,et al.  Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[142]  R. W. Humphry,et al.  Changes in cardiovascular risk factors in relation to increasing ethnic inequalities in cardiovascular mortality: comparison of cross-sectional data in the Health Surveys for England 1999 and 2004 , 2013, BMJ Open.

[143]  C. Fischbacher,et al.  Myocardial infarction incidence and survival by ethnic group: Scottish Health and Ethnicity Linkage retrospective cohort study , 2013, BMJ Open.

[144]  Daniel E Forman,et al.  Exercise standards for testing and training: a scientific statement from the American Heart Association. , 2013, Circulation.

[145]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[146]  S. Maes,et al.  Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials , 2013, European journal of preventive cardiology.

[147]  R. Bhopal,et al.  Sizable variations in circulatory disease mortality by region and country of birth in six European countries. , 2013, European journal of public health.

[148]  C. Vlachopoulos,et al.  Erectile dysfunction in the cardiovascular patient. , 2013, European heart journal.

[149]  Z. Kabir,et al.  Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland , 2013, BMJ Open.

[150]  R. Peters,et al.  Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial , 2013, Heart.

[151]  D. Gaudet,et al.  DNA methylation variations at CETP and LPL gene promoter loci: new molecular biomarkers associated with blood lipid profile variability. , 2013, Atherosclerosis.

[152]  R. Perera,et al.  Pharmacological interventions for smoking cessation: an overview and network meta-analysis. , 2013, The Cochrane database of systematic reviews.

[153]  P. Mills,et al.  A Meta-Analysis of Mental Health Treatments and Cardiac Rehabilitation for Improving Clinical Outcomes and Depression Among Patients With Coronary Heart Disease , 2013, Psychosomatic medicine.

[154]  J. Ioannidis,et al.  Bias in associations of emerging biomarkers with cardiovascular disease. , 2013, JAMA internal medicine.

[155]  Lee Hooper,et al.  Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.

[156]  M. O'Rourke,et al.  Guidelines on guidelines: focus on isolated systolic hypertension in youth. , 2013, Journal of hypertension.

[157]  Bruce Neal,et al.  Internet-based treatment for older adults with depression and co-morbid cardiovascular disease: protocol for a randomised, double-blind, placebo controlled trial , 2011, BMC Psychiatry.

[158]  A. Castellanos,et al.  Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care , 2013, BMC Family Practice.

[159]  Mikael Fogelholm,et al.  Faculty of 1000 evaluation for Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013 .

[160]  P. Hall,et al.  Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.

[161]  Gelin Xu,et al.  Dietary fiber consumption and risk of stroke , 2013, European Journal of Epidemiology.

[162]  F. Chaloupka,et al.  Assessing the potential effectiveness of food and beverage taxes and subsidies for improving public health: a systematic review of prices, demand and body weight outcomes , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[163]  Huidong Shi,et al.  A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males , 2013, PloS one.

[164]  C. Vlachopoulos,et al.  Prediction of Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction: A Systematic Review and Meta-Analysis of Cohort Studies , 2012, Circulation. Cardiovascular quality and outcomes.

[165]  M. Leal Hernández,et al.  [Cardiovascular risk of immigrants living in Spain according to origin and years of stay]. , 2013, Atencion primaria.

[166]  J. Murabito,et al.  Sustained and shorter bouts of physical activity are related to cardiovascular health. , 2013, Medicine and science in sports and exercise.

[167]  M. Özkaya,et al.  Action to Control Cardiovascular Risk in Diabetes , 2013 .

[168]  B. Whalley,et al.  Psychological Interventions for Coronary Heart Disease: Cochrane Systematic Review and Meta-analysis , 2014, International Journal of Behavioral Medicine.

[169]  O. Franco,et al.  [Population-level changes to promote cardiovascular health]. , 2013, Vnitrni lekarstvi.

[170]  Shah Ebrahim,et al.  [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)]. , 2013, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[171]  C. Gross,et al.  Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. , 2012, Journal of the American College of Cardiology.

[172]  C. Fischbacher,et al.  Ethnic variations in the incidence and mortality of stroke in the Scottish Health and Ethnicity Linkage Study of 4.65 million people , 2012, European journal of preventive cardiology.

[173]  T. Blakely,et al.  Food Pricing Strategies, Population Diets, and Non-Communicable Disease: A Systematic Review of Simulation Studies , 2012, PLoS medicine.

[174]  R. T. Lie,et al.  Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study , 2012, BMJ : British Medical Journal.

[175]  G. De Backer,et al.  Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project. , 2012, European heart journal.

[176]  M. Thun,et al.  Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large Pooled Cohort Analysis , 2012, PLoS medicine.

[177]  Donal N. Gorman,et al.  Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[178]  M. Buxton,et al.  Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach , 2012, BMJ Open.

[179]  J. Seidell,et al.  A trial of sugar-free or sugar-sweetened beverages and body weight in children. , 2012, The New England journal of medicine.

[180]  Y. Jang,et al.  A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). , 2012, Journal of the American College of Cardiology.

[181]  L. Smeeth,et al.  Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study , 2012, The Journal of infectious diseases.

[182]  H. Heidbuchel,et al.  Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR (Part II) , 2012, European journal of preventive cardiology.

[183]  Geoffrey C. Williams,et al.  Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. , 2012, The American journal of cardiology.

[184]  S. Wild,et al.  Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study , 2012, PLoS medicine.

[185]  A. Goldhirsch,et al.  Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[186]  Andrew Steptoe,et al.  Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data , 2012, The Lancet.

[187]  D. Mozaffarian,et al.  Population Approaches to Improve Diet, Physical Activity, and Smoking Habits: A Scientific Statement From the American Heart Association , 2012, Circulation.

[188]  E. Ntzani,et al.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.

[189]  P. Doraiswamy,et al.  Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. , 2012, Journal of the American College of Cardiology.

[190]  I. Holme,et al.  Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease. , 2012, Arthritis and rheumatism.

[191]  Marcello Tonelli,et al.  Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study , 2012, The Lancet.

[192]  D. Goff,et al.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.

[193]  Giel Nijpels,et al.  Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. , 2012, JAMA.

[194]  C. Snyder,et al.  Exercise interventions on health-related quality of life for people with cancer during active treatment. , 2012, The Cochrane database of systematic reviews.

[195]  John Spertus,et al.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study , 2012, The Lancet.

[196]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[197]  A. Hofman,et al.  A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. , 2012, Atherosclerosis.

[198]  A. Butterworth,et al.  Clinical utility of genetic variants for cardiovascular risk prediction: a futile exercise or insufficient data? , 2012, Circulation. Cardiovascular genetics.

[199]  A. Peters,et al.  Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts , 2012, PloS one.

[200]  T. Vos,et al.  Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease? , 2012, PloS one.

[201]  S. Blair,et al.  Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy , 2012, BDJ.

[202]  C. Currie,et al.  Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. , 2012, The Journal of clinical endocrinology and metabolism.

[203]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[204]  A. Khera,et al.  Association Between Family History and Coronary Heart Disease Death Across Long-Term Follow-Up in Men: The Cooper Center Longitudinal Study , 2012, Circulation.

[205]  P. Nilsson,et al.  Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies , 2012, European Journal of Epidemiology.

[206]  Lu Gao,et al.  Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data , 2012, The Lancet.

[207]  A. Banerjee,et al.  A review of family history of cardiovascular disease: risk factor and research tool , 2012, International journal of clinical practice.

[208]  E. Guallar,et al.  Survey of physicians’ practices in the control of cardiovascular risk factors: the EURIKA study , 2012, European journal of preventive cardiology.

[209]  E. Vartiainen,et al.  Cardiovascular risk age: concepts and practicalities , 2012, Heart.

[210]  M. Woodward,et al.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. , 2012, JAMA.

[211]  C. Koning,et al.  High risk of symptomatic cardiac events in childhood cancer survivors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[212]  M. L. Larsen,et al.  Population Screening for Coronary Artery Calcification Does Not Increase Mental Distress and the Use of Psychoactive Medication , 2012, Journal of thoracic imaging.

[213]  M. Løchen,et al.  Use of snus during pregnancy is not without risk. , 2012, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[214]  Marc P. Bonaca,et al.  Vorapaxar in the secondary prevention of atherothrombotic events. , 2012, The New England journal of medicine.

[215]  Heather M. Tavel,et al.  Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients , 2012, Circulation.

[216]  G. Mancia,et al.  Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management – is nice always good? , 2012, Journal of hypertension.

[217]  N. Sattar,et al.  HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards , 2012, Diabetologia.

[218]  J. Ioannidis,et al.  Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease. , 2012, Circulation research.

[219]  Bonnie Spring,et al.  Healthy Lifestyle Through Young Adulthood and the Presence of Low Cardiovascular Disease Risk Profile in Middle Age: The Coronary Artery Risk Development in (Young) Adults (CARDIA) Study , 2012, Circulation.

[220]  M. Jeong,et al.  Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study , 2012, Circulation.

[221]  J. Manson,et al.  Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. , 2012, Archives of internal medicine.

[222]  John Simes,et al.  Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy , 2012, PloS one.

[223]  J. Barth,et al.  Association Between Type D Personality and Prognosis in Patients with Cardiovascular Diseases: a Systematic Review and Meta-analysis , 2012, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[224]  M. Woodward,et al.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. , 2012, JAMA.

[225]  P. Toth.  Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis , 2012 .

[226]  Roy J. Shephard,et al.  2011 Compendium of Physical Activities: A Second Update of Codes and MET Values , 2012 .

[227]  Thomas J. Wang,et al.  Biomarkers and cardiovascular risk assessment for primary prevention: an update. , 2012, Clinical chemistry.

[228]  Peter C Gøtzsche,et al.  General health checks in adults for reducing morbidity and mortality from disease. , 2012, The Cochrane database of systematic reviews.

[229]  Mark D. Huffman,et al.  Fixed-dose combination therapy for the prevention of cardiovascular disease. , 2012, The Cochrane database of systematic reviews.

[230]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[231]  A. Singleton,et al.  Informed Choice in Direct-to-Consumer Genetic Testing (DTCGT) Websites: A Content Analysis of Benefits, Risks, and Limitations , 2012, Journal of Genetic Counseling.

[232]  E. Ingelsson,et al.  Birth Characteristics and Subsequent Risks of Maternal Cardiovascular Disease: Effects of Gestational Age and Fetal Growth , 2011, Circulation.

[233]  William Weintraub,et al.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.

[234]  S. Peters,et al.  Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review , 2011, Heart.

[235]  M. Hill,et al.  Community Outreach and Cardiovascular Health (COACH) Trial: A Randomized, Controlled Trial of Nurse Practitioner/Community Health Worker Cardiovascular Disease Risk Reduction in Urban Community Health Centers , 2011, Circulation. Cardiovascular quality and outcomes.

[236]  Kenneth W Lin,et al.  Nicotine receptor partial agonists for smoking cessation. , 2011, American family physician.

[237]  Matthias Egger,et al.  Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. , 2011, International journal of epidemiology.

[238]  Duo Li,et al.  Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies , 2011, Public Health Nutrition.

[239]  B. Burnand,et al.  Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. , 2011, Archives of internal medicine.

[240]  Martin O'Flaherty,et al.  Rapid mortality falls after risk-factor changes in populations , 2011, The Lancet.

[241]  I-Min Lee,et al.  Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis , 2011, Circulation.

[242]  S. Kaul,et al.  Fibrates in the treatment of dyslipidemias--time for a reassessment. , 2011, The New England journal of medicine.

[243]  N. Sattar,et al.  Risk Prediction in Cardiovascular Medicine Integrating Information From Novel Risk Factors With Calculated Risks The Critical Impact of Risk Factor Prevalence , 2011 .

[244]  A. K. Jenum,et al.  Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians , 2011, BMC public health.

[245]  S. Ebrahim,et al.  Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.

[246]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[247]  K. Stronks,et al.  Diabetes Prevalence in Populations of South Asian Indian and African Origins: A Comparison of England and The Netherlands , 2011, Epidemiology.

[248]  B. Franklin,et al.  American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. , 2011, Medicine and science in sports and exercise.

[249]  P. Kolh,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, European heart journal.

[250]  Luc Vanhees,et al.  Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[251]  R. Fagard.  Exercise therapy in hypertensive cardiovascular disease. , 2011, Progress in cardiovascular diseases.

[252]  R. Mathur,et al.  Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[253]  J. Borén,et al.  Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management , 2011, European heart journal.

[254]  Eliseo Guallar,et al.  Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study , 2011, European heart journal.

[255]  P. Barter,et al.  Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. , 2011, Journal of the American College of Cardiology.

[256]  M. Ashworth,et al.  Ethnic differences in blood pressure monitoring and control in south east London. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[257]  Kjeld Hermansen,et al.  The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? , 2011, The American journal of clinical nutrition.

[258]  Peter H Whincup,et al.  Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. , 2011, Archives of internal medicine.

[259]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.

[260]  A. Khera,et al.  Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.

[261]  C. Elley,et al.  Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[262]  T. Nawrot,et al.  Public health importance of triggers of myocardial infarction: a comparative risk assessment , 2011, The Lancet.

[263]  W. Ghali,et al.  Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies , 2011, BMJ : British Medical Journal.

[264]  W. Ghali,et al.  Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis , 2011, BMJ : British Medical Journal.

[265]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[266]  C. Coupland,et al.  The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study. , 2011, Vaccine.

[267]  B. Vessby,et al.  Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). , 2011, Archives of internal medicine.

[268]  Florence Dumas,et al.  Sports-Related Sudden Death in the General Population , 2010, Circulation.

[269]  R. Shephard.  Body-Mass Index and Mortality among 1.46 Million White Adults , 2011 .

[270]  Ian Graham,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, Atherosclerosis.

[271]  J. McMurray,et al.  A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. , 2011, American heart journal.

[272]  M. Stelmach,et al.  The Toronto Charter for Physical Activity: A Global Call for Action. , 2012, Journal of physical activity & health.

[273]  T. Bjørge,et al.  Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway , 2011, European Journal of Epidemiology.

[274]  Do Peterson,et al.  Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.

[275]  Ž. Reiner,et al.  Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey. , 2010, Atherosclerosis.

[276]  S. Yusuf,et al.  The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions. , 2010, Circulation.

[277]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[278]  A. Cass.  Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. , 2010, American heart journal.

[279]  P. Vokonas,et al.  Ischemic Heart Disease and Stroke in Relation to Blood DNA Methylation , 2010, Epidemiology.

[280]  Rosanna Abbate,et al.  Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. , 2010, The American journal of clinical nutrition.

[281]  L. Peltonen,et al.  A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses , 2010, The Lancet.

[282]  J. Borén,et al.  Lipoprotein(a) as a cardiovascular risk factor: current status , 2010, European heart journal.

[283]  M. Sandhu,et al.  Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study , 2010, Heart.

[284]  C. Coupland,et al.  Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case–control study , 2010, Canadian Medical Association Journal.

[285]  Robert C Hornik,et al.  Use of mass media campaigns to change health behaviour , 2010, The Lancet.

[286]  Dirk De Bacquer,et al.  EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[287]  J. I. Cuende,et al.  How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. , 2010, European heart journal.

[288]  R. Fleming,et al.  Alcohol-use disorders: preventing the development of hazardous and harmful drinking , 2010 .

[289]  H. McGee,et al.  Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[290]  D. Mozaffarian,et al.  Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults A Scientific Statement From the American Heart Association Endorsed by the Preventive Cardiovascular Nurses Association and the Society of Behavioral Medicine , 2010 .

[291]  Ralph D'Agostino,et al.  Risk Prediction in Cardiovascular Medicine Cardiovascular Risk-Estimation Systems in Primary Prevention Do They Differ ? Do They Make a Difference ? Can We See the Future ? , 2010 .

[292]  L. Moran,et al.  Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. , 2010, Human reproduction update.

[293]  The Emerging Risk Factors Collaboration.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.

[294]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[295]  J. Denollet,et al.  Anxiety and risk of incident coronary heart disease : A meta-analysis , 2010 .

[296]  K. Stronks,et al.  A cross-national comparative study of smoking prevalence and cessation between English and Dutch South Asian and African origin populations: the role of national context. , 2010, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[297]  N. Wareham,et al.  Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study , 2010, BMJ : British Medical Journal.

[298]  J. Denollet,et al.  Prognostic Association of Anxiety Post Myocardial Infarction With Mortality and New Cardiac Events: A Meta-Analysis , 2010, Psychosomatic medicine.

[299]  F. Diderichsen,et al.  Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study , 2010, European Journal of Clinical Pharmacology.

[300]  T. Hansen,et al.  Risk prediction is improved by adding markers of subclinical organ damage to SCORE. , 2010, European heart journal.

[301]  A. Klatsky.  Alcohol and cardiovascular mortality: common sense and scientific truth. , 2010, Journal of the American College of Cardiology.

[302]  C. Vlachopoulos,et al.  Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness , 2011 .

[303]  J. Senges,et al.  The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction , 2010, Heart.

[304]  M. Kivimaki,et al.  Association of socioeconomic position with health behaviors and mortality. , 2010, JAMA.

[305]  R. von Känel,et al.  Lack of Social Support in the Etiology and the Prognosis of Coronary Heart Disease: A Systematic Review and Meta-Analysis , 2010, Psychosomatic medicine.

[306]  P. Sandercock,et al.  Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. , 2010, JAMA.

[307]  Yasuo Ohashi,et al.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2010, The Lancet.

[308]  Helge Hebestreit,et al.  Effect of school based physical activity programme (KISS) on fitness and adiposity in primary schoolchildren: cluster randomised controlled trial , 2010, BMJ : British Medical Journal.

[309]  S. Yusuf,et al.  Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.

[310]  J. Langhoff‐Roos,et al.  Preterm delivery and risk of subsequent cardiovascular morbidity and type‐II diabetes in the mother , 2010, BJOG : an international journal of obstetrics and gynaecology.

[311]  Rajiv Nariani,et al.  Effects of cardiac rehabilitation referral strategies on referral and enrollment rates , 2010, Nature Reviews Cardiology.

[312]  N. Poulter,et al.  Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis , 2010, Hypertension.

[313]  Martin G Myers,et al.  Measurement of blood pressure in the office: recognizing the problem and proposing the solution. , 2010, Hypertension.

[314]  Paul Dendale,et al.  Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[315]  F. Veglia,et al.  Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. , 2010, Journal of the American College of Cardiology.

[316]  D. Symmons,et al.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis , 2009, Annals of the rheumatic diseases.

[317]  G. Moneta,et al.  Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .

[318]  G. De Backer,et al.  Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality. , 2010, International journal of cardiology.

[319]  P. Plans-Rubió.  The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices , 2010, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[320]  Tiffany Moxham,et al.  Home-based versus centre-based cardiac rehabilitation. , 2010, The Cochrane database of systematic reviews.

[321]  A. Gorgels,et al.  Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[322]  J. Bressler,et al.  Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study. , 2010, American journal of epidemiology.

[323]  Susan T. Stewart,et al.  Forecasting the effects of obesity and smoking on U.S. life expectancy. , 2009, The New England journal of medicine.

[324]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[325]  G. Tognoni,et al.  Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.

[326]  J. Newell,et al.  Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial , 2009, BMJ : British Medical Journal.

[327]  Barbara P. Yawn,et al.  Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[328]  P. Vokonas,et al.  Periodontitis and incidence of cerebrovascular disease in men , 2009, Annals of neurology.

[329]  P. Whincup,et al.  HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. , 2009, Atherosclerosis.

[330]  Robert Dufour,et al.  Canadian Cardiovascular Society / Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations , 2009 .

[331]  J. Oppert,et al.  Downward trends in the prevalence of childhood overweight in the setting of 12-year school- and community-based programmes , 2009, Public Health Nutrition.

[332]  I. Graham,et al.  Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. , 2009, Journal of the American College of Cardiology.

[333]  Jiang He,et al.  Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes , 2009, Annals of Internal Medicine.

[334]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[335]  L. Fleisher,et al.  Cardiovascular Evaluation and Management of Severely Obese Patients Undergoing Surgery: A Science Advisory From the American Heart Association , 2009, Circulation.

[336]  Jeroen J. Bax,et al.  Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood , 2009, Heart.

[337]  P Michael Ho,et al.  Medication Adherence: Its Importance in Cardiovascular Outcomes , 2009, Circulation.

[338]  Adrian Bauman,et al.  Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[339]  Ian Graham,et al.  How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[340]  B. Sibai,et al.  Hypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the Mother , 2009, Hypertension.

[341]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[342]  N. Sattar,et al.  Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.

[343]  A. Hingorani,et al.  Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis , 2009, The Lancet.

[344]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[345]  Brian D Johnston,et al.  Pilot evaluation of a walking school bus program in a low-income, urban community , 2009, BMC public health.

[346]  E. Regidor,et al.  [Mortality from cardiovascular diseases in immigrants residing in Madrid]. , 2009, Medicina clinica.

[347]  G. Mancia,et al.  When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal , 2009, Journal of hypertension.

[348]  P. Anderson.  Global alcohol policy and the alcohol industry , 2009, Current opinion in psychiatry.

[349]  S. Achenbach,et al.  Clinical characteristics of patients with obstructive coronary lesions in the absence of coronary calcification: an evaluation by coronary CT angiography , 2009, Heart.

[350]  E. Faerstein,et al.  A DICTIONARY OF EPIDEMIOLOGY , 2016 .

[351]  D. Levy,et al.  Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005 , 2009, Circulation.

[352]  Gert Mayer,et al.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.

[353]  Jörg Hausleiter,et al.  Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease. , 2009, JACC. Cardiovascular imaging.

[354]  K. Kotseva,et al.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[355]  J. Veerman,et al.  By how much would limiting TV food advertising reduce childhood obesity? , 2009, European journal of public health.

[356]  A. Steptoe,et al.  The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. , 2009, Journal of the American College of Cardiology.

[357]  T. Jørgensen,et al.  Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. , 2009, Preventive medicine.

[358]  D. Wald,et al.  Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials , 2010 .

[359]  H Löllgen,et al.  Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. , 2009, International journal of sports medicine.

[360]  Matthew J. Salois,et al.  Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies. , 2009, Addiction.

[361]  John P A Ioannidis,et al.  Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers , 2009, Circulation. Cardiovascular genetics.

[362]  Bryan K. Smith,et al.  American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. , 2009, Medicine and science in sports and exercise.

[363]  Jennifer G. Robinson,et al.  Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. , 2009, Journal of the American College of Cardiology.

[364]  S. Kimmel,et al.  Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in Veterans , 2009, Circulation.

[365]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[366]  N. Schneiderman,et al.  Stress Reduction Prolongs Life in Women With Coronary Disease: The Stockholm Women’s Intervention Trial for Coronary Heart Disease (SWITCHD) , 2009, Circulation. Cardiovascular quality and outcomes.

[367]  S. Schinner.  Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[368]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[369]  Nikolaus Marx,et al.  The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. , 2008, The American journal of cardiology.

[370]  L. Tavazzi,et al.  Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. , 2008, Archives of internal medicine.

[371]  A. Garden,et al.  Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[372]  M. Pencina,et al.  C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study , 2008, Circulation. Cardiovascular quality and outcomes.

[373]  Vivian Gu,et al.  Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. , 2008, The New England journal of medicine.

[374]  T. Young,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[375]  E. Regidor,et al.  Heterogeneity in cause-specific mortality according to birthplace in immigrant men residing in Madrid, Spain. , 2008, Annals of epidemiology.

[376]  Yutaka Imai,et al.  European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring , 2008, Journal of hypertension.

[377]  Steven Hawken,et al.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study , 2008, The Lancet.

[378]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.

[379]  David Ames,et al.  Feasibility of conducting a primary prevention trial of low‐dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study , 2008, The Medical journal of Australia.

[380]  A. Sheikh,et al.  Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 , 2008, BMJ : British Medical Journal.

[381]  R. Auer,et al.  Efficacy of In-Hospital Multidimensional Interventions of Secondary Prevention After Acute Coronary Syndrome: A Systematic Review and Meta-Analysis , 2008, Circulation.

[382]  O. Faergeman,et al.  Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial , 2008, The Lancet.

[383]  A. Hoes,et al.  Different Distribution of Cardiovascular Risk Factors According to Ethnicity: A Study in a High Risk Population , 2008, Journal of Immigrant and Minority Health.

[384]  B Neal,et al.  Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials , 2008, BMJ : British Medical Journal.

[385]  Heidemarie Keller,et al.  Absolute Cardiovascular Disease Risk and Shared Decision Making in Primary Care: A Randomized Controlled Trial , 2008, The Annals of Family Medicine.

[386]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[387]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[388]  S. Reis,et al.  Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. , 2008, The Journal of clinical endocrinology and metabolism.

[389]  P. Vokonas,et al.  Age-Dependent Associations Between Chronic Periodontitis/Edentulism and Risk of Coronary Heart Disease , 2008, Circulation.

[390]  Meena Kumari,et al.  Work stress and coronary heart disease: what are the mechanisms? , 2008, European heart journal.

[391]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[392]  K. Kalantar-Zadeh,et al.  Effect of Obesity on Short‐ and Long‐term Mortality Postcoronary Revascularization: A Meta‐analysis , 2008, Obesity.

[393]  Christopher B. Kendall,et al.  Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[394]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[395]  J. Robson,et al.  Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease , 2007, Heart.

[396]  W. Howard.  Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study , 2008 .

[397]  S. Allender,et al.  European cardiovascular disease statistics , 2008 .

[398]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[399]  J. Smoller,et al.  Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. , 2007, Archives of general psychiatry.

[400]  Alessandro Filippi,et al.  Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins , 2007, Trials.

[401]  M. Nieminen,et al.  Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death: The LIFE Study , 2007, Circulation.

[402]  M. Rosato,et al.  Trends for coronary heart disease and stroke mortality among migrants in England and Wales, 1979–2003: slow declines notable for some groups , 2007, Heart.

[403]  L. Talbot,et al.  Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging. , 2007, Preventive medicine.

[404]  A. Algra,et al.  Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. , 2007, The Cochrane database of systematic reviews.

[405]  J. Hippisley-Cox,et al.  Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study , 2007, BMJ : British Medical Journal.

[406]  E. Schiffrin,et al.  Chronic Kidney Disease: Effects on the Cardiovascular System , 2007, Circulation.

[407]  S. Kalra,et al.  EXERCISE AND ACUTE CARDIOVASCULAR EVENTS: PLACING THE RISKS INTO PERSPECTIVE: A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATION COUNCIL ON NUTRITION, PHYSICAL ACTIVITY, AND METABOLISM AND THE COUNCIL ON CLINICAL CARDIOLOGY , 2007 .

[408]  E. Eaker,et al.  Marital Status, Marital Strain, and Risk of Coronary Heart Disease or Total Mortality: The Framingham Offspring Study , 2007, Psychosomatic medicine.

[409]  E. Benjamin,et al.  Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study). , 2007, The American journal of cardiology.

[410]  Fernando Costa,et al.  Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. , 2007, Circulation.

[411]  S. Jee,et al.  Age at menopause and cause-specific mortality in South Korean women: Kangwha Cohort Study. , 2007, Maturitas.

[412]  N. Cook,et al.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) , 2007, BMJ : British Medical Journal.

[413]  Klaus G. Grunert,et al.  A review of European research on consumer response to nutrition information on food labels , 2007, Journal of Public Health.

[414]  L. Sandvik,et al.  Effects of a home-based intervention program on anxiety and depression 6 months after coronary artery bypass grafting: a randomized controlled trial. , 2007, Journal of psychosomatic research.

[415]  F. Kronenberg,et al.  Lipoprotein metabolism and lipid management in chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.

[416]  S. Giampaoli.  CUORE: a sustainable cardiovascular disease prevention strategy , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[417]  R Brian Haynes,et al.  Interventions to enhance medication adherence in chronic medical conditions: a systematic review. , 2007, Archives of internal medicine.

[418]  H. Bartelink,et al.  Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. , 2007, Journal of the National Cancer Institute.

[419]  J. Danesh,et al.  Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies , 2007, Circulation.

[420]  W. Elliott,et al.  Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis , 2007, The Lancet.

[421]  M. Løchen,et al.  Tobacco images and texts in Norwegian magazines and newspapers , 2007, Scandinavian journal of public health.

[422]  M. Woodward,et al.  Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) , 2005, Heart.

[423]  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension , 2007 .

[424]  Carrie D. Heitzler,et al.  Evaluation of a national physical activity intervention for children: VERB campaign, 2002-2004. , 2007, American journal of preventive medicine.

[425]  P. Ridker,et al.  Impact of Traditional and Novel Risk Factors on the Relationship Between Socioeconomic Status and Incident Cardiovascular Events , 2006, Circulation.

[426]  C. Agyemang,et al.  Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: the Amsterdam Health Monitor Survey , 2006, Journal of hypertension.

[427]  F. Montorsi,et al.  Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. , 2006, European urology.

[428]  Philippe Amouyel,et al.  Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. , 2006, The Journal of nutrition.

[429]  R. Kravitz,et al.  Physician communication when prescribing new medications. , 2006, Archives of internal medicine.

[430]  V. Montori,et al.  Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies , 2006, The Lancet.

[431]  Ross T Tsuyuki,et al.  A meta-analysis of the association between adherence to drug therapy and mortality , 2006, BMJ : British Medical Journal.

[432]  H. Meyer,et al.  Cardiovascular disease risk factors among five major ethnic groups in Oslo, Norway: the Oslo Immigrant Health Study , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[433]  J. Danesh,et al.  Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature‐based meta‐analysis of prospective studies , 2006, Journal of internal medicine.

[434]  Roberto Sega,et al.  Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure , 2006, Hypertension.

[435]  J. Sundquist,et al.  Are there differences in all-cause and coronary heart disease mortality between immigrants in Sweden and in their country of birth? A follow-up study of total populations , 2006, BMC public health.

[436]  Patrice Cacoub,et al.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. , 2006, The New England journal of medicine.

[437]  D. Mozaffarian,et al.  Trans fatty acids and cardiovascular disease. , 2006, The New England journal of medicine.

[438]  Raimund Erbel,et al.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.

[439]  D. Prabhakaran,et al.  Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. , 2006, Atherosclerosis.

[440]  C. Nowson,et al.  Fruit and vegetable consumption and stroke: meta-analysis of cohort studies , 2006, The Lancet.

[441]  T. Stockwell.  A Review Of Research Into The Impacts Of Alcohol Warning Labels On Attitudes And Behaviour , 2006 .

[442]  D. Couper,et al.  Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. , 2005, Atherosclerosis.

[443]  M. Whooley,et al.  Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. , 2005, Archives of internal medicine.

[444]  Jennifer G. Robinson,et al.  Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. , 2005, Journal of the American College of Cardiology.

[445]  A. Lippman.  Adherence to medication. , 2005, The New England journal of medicine.

[446]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[447]  Erland Erdmann,et al.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.

[448]  K. Mak,et al.  Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting. , 2005, American heart journal.

[449]  S. Pedersen,et al.  Posttraumatic Stress Disorder in the Wake of Heart Disease: Prevalence, Risk Factors, and Future Research Directions , 2005, Psychosomatic medicine.

[450]  Bo Christensen,et al.  Motivational interviewing: a systematic review and meta-analysis. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[451]  Ž. Reiner,et al.  [Concomitant use of statins and cytochrome P 450 inhibitors in Croatia]. , 2005, Lijecnicki vjesnik.

[452]  E. Vartiainen,et al.  Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. , 2005, Journal of public health.

[453]  C. Lockwood,et al.  Effectiveness of nurse‐led cardiac clinics in adult patients with a diagnosis of coronary heart disease , 2005, International journal of evidence-based healthcare.

[454]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice , 2004 .

[455]  J. Critchley,et al.  Smoking cessation for the secondary prevention of coronary heart disease. , 2012, The Cochrane database of systematic reviews.

[456]  R. Hubbard,et al.  Risk of myocardial infarction and stroke after acute infection or vaccination. , 2004, The New England journal of medicine.

[457]  Volkan Ozduran,et al.  Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. , 2004, JAMA.

[458]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[459]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[460]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[461]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[462]  T. Lauritzen,et al.  No long-term psychological reaction to information about increased risk of coronary heart disease in general practice , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[463]  D. Rizzoni,et al.  Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients , 2004, Hypertension.

[464]  Paige E. Scalf,et al.  Cardiovascular fitness, cortical plasticity, and aging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[465]  C. Herrmann-Lingen,et al.  Screening for psychosocial risk factors in patients with coronary heart disease-recommendations for clinical practice , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[466]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[467]  D. Atar,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[468]  L. Stead,et al.  Physician advice for smoking cessation. , 2004, The Cochrane database of systematic reviews.

[469]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2004, European heart journal.

[470]  I. McInnes,et al.  Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. , 2003, Circulation.

[471]  Michael Williams.  Risk assessment and management of cardiovascular disease in New Zealand. , 2003, The New Zealand medical journal.

[472]  N J Wald,et al.  A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.

[473]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[474]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[475]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[476]  G. Prescott,et al.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.

[477]  N. Kerse,et al.  Effectiveness of counselling patients on physical activity in general practice: cluster randomised controlled trial , 2003, BMJ : British Medical Journal.

[478]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[479]  P. Hall,et al.  Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women , 2003, BMJ : British Medical Journal.

[480]  J. Simpson,et al.  Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care , 2003, BMJ : British Medical Journal.

[481]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[482]  F. Cappuccio,et al.  Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study , 2002, BMJ : British Medical Journal.

[483]  G. MacGregor,et al.  Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health , 2002, Journal of Human Hypertension.

[484]  P. Schnohr,et al.  Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study , 2002, Journal of epidemiology and community health.

[485]  J. Guralnik,et al.  The Ankle Brachial Index Is Associated with Leg Function and Physical Activity: The Walking and Leg Circulation Study , 2002, Annals of Internal Medicine.

[486]  B. Jensen,et al.  Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[487]  Jixian Wang,et al.  Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies , 2002, BMJ : British Medical Journal.

[488]  N. Weissman,et al.  Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments. , 2002, The American journal of cardiology.

[489]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[490]  Renu Virmani,et al.  Morphological Predictors of Arterial Remodeling in Coronary Atherosclerosis , 2002, Circulation.

[491]  G. Burell,et al.  Women’s hearts need special treatment , 2002, International journal of behavioral medicine.

[492]  K. Furie,et al.  A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.

[493]  J. Kerr,et al.  Six-month observational study of prompted stair climbing. , 2001, Preventive medicine.

[494]  P. Armstrong,et al.  Randomised trials of secondary prevention programmes in coronary heart disease: systematic review , 2001, BMJ : British Medical Journal.

[495]  Reza Emdad,et al.  Employee Effects of an Educational Program for Managers at an Insurance Company , 2001, Psychosomatic medicine.

[496]  S. Macdonald,et al.  The effects of introducing or lowering legal per se blood alcohol limits for driving: an international review. , 2001, Accident; analysis and prevention.

[497]  E. Howley.  Type of activity: resistance, aerobic and leisure versus occupational physical activity. , 2001, Medicine and science in sports and exercise.

[498]  W. Hiatt,et al.  Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.

[499]  H. Hecht,et al.  Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women. , 2001, Journal of the American College of Cardiology.

[500]  R. Virmani,et al.  Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with 'healthy' subjects dying out of hospital. , 2001, Atherosclerosis.

[501]  G Parati,et al.  Blood pressure measuring devices: recommendations of the European Society of Hypertension , 2001, BMJ : British Medical Journal.

[502]  M. Budoff,et al.  Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons. , 2001, International journal of cardiology.

[503]  M. Reiser,et al.  Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. , 2001, Journal of the American College of Cardiology.

[504]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.

[505]  P. R. R. Ecurrent,et al.  EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .

[506]  N. Schneiderman,et al.  Marital stress worsens prognosis in women with coronary heart disease: The Stockholm Female Coronary Risk Study. , 2000, JAMA.

[507]  C Warlow,et al.  Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. , 2000, Stroke.

[508]  M. Mckee,et al.  The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox , 2000, Journal of epidemiology and community health.

[509]  R H Hruban,et al.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[510]  P. Sandercock,et al.  Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack. , 2000, The Cochrane database of systematic reviews.

[511]  M. Gorostidi,et al.  LONG-TERM PROGNOSIS OF HYPERTENSION IN PREGNANCY , 1999, Hypertension in pregnancy.

[512]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[513]  Orton,et al.  EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .

[514]  S. Ebrahim,et al.  Multiple risk factor interventions for primary prevention of coronary heart disease. , 2000, The Cochrane database of systematic reviews.

[515]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[516]  R. Room,et al.  Privatizing alcohol sales and alcohol consumption: evidence and implications. , 1999, Addiction.

[517]  P. Whelton,et al.  Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. , 1999, The New England journal of medicine.

[518]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[519]  L. F. Fajardo.  Is the pathology of radiation injury different in small vs large blood vessels? , 1999, Cardiovascular radiation medicine.

[520]  Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. , 1999, Atherosclerosis.

[521]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[522]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[523]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[524]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[525]  J. Vestbo,et al.  Smoking and risk of myocardial infarction in women and men: longitudinal population study , 1998, BMJ.

[526]  F. O. Simpson.  Long-term cost and life-expectancy consequences of hypertension. , 1998, Journal of hypertension.

[527]  N J Wald,et al.  Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence , 1997, BMJ.

[528]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[529]  B. Steele,et al.  The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. , 1996, The New England journal of medicine.

[530]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[531]  J. Henningfield.  Nicotine medications for smoking cessation. , 1995, The New England journal of medicine.

[532]  P. Thompson,et al.  ACSM's Guidelines for Exercise Testing and Prescription , 1995 .

[533]  R Doll,et al.  Mortality in relation to smoking: 40 years' observations on male British doctors , 1994, BMJ.

[534]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, European heart journal.

[535]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[536]  M. Leppert,et al.  Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. , 1993, The American journal of cardiology.

[537]  T. Dragani,et al.  Libri Ricevuti: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1992 .

[538]  R. Mensink,et al.  Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[539]  D. Jacobs,et al.  Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial , 1992 .

[540]  D. Jacobs,et al.  Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[541]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[542]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[543]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[544]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.

[545]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.

[546]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.